Research Article

Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease

Table 1

Clinical characteristics of the study population.

IndexControl ()SCAD () value

Gender (male/female)12/814/60.51^
Age (years)57 (52, 62)64 (52, 68)0.10#
BMI (kg/m2)0.44
Diabetes (%)3 (15.0)6 (30.0)0.26^
Hypertension (%)8 (40.0)7 (35.0)0.74^
SBP (mmHg)0.89
DBP (mmHg)0.49
Creatinine (μmol/L)0.09
Glucose (mmol/L)5.0 (4.6, 5.3)5.3 (4.7, 6.4)0.17#
ALT (U/L)20.0 (15.0, 27.0)24.0 (14.0, 33.0)0.45#
AST (U/L)0.29
LDL-C (mmol/L)0.56
HDL-C (mmol/L)0.22
TG (mmol/L)1.9 (1.4, 2.6)1.8 (1.5, 2.0)0.55#
TC (mmol/L)4.9 (3.5, 5.5)4.6 (4.1, 5.3)1.00#
hs-cTnT (pg/mL)5.4 (5.0, 7.1)8.6 (6.4, 55.2)<0.01#

SCAD: stable coronary artery disease; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; TC: total cholesterol; hs-cTnT: high-sensitive- (hs-) cardiac troponin T; ^chi-square test; #nonparametric test.